COMP <GO>
CROX vs PG // NET PROFIT MARGIN
Crocs Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CROX 4
— PG 11
▲ NET PROFIT MARGIN LEADER: PG
LAST: $150.52 (+0.17%) • MKT CAP: $7.20B
net-margins
-2.00%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
net-margins
19.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CROX VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CROX | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 58.30% | 51.20% | +7.10 | CROX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 25.40% | -20.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 43.0x | 16.2x | +26.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 9.15% | 3.77% | +5.38 | CROX | /fcf-yield <GO> |
| Operating Margin | 3.70% | 24.30% | -20.60 | PG | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -2.00% | 19.00% | -21.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 0.30% | -1.80 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 5.59 | -1.78 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.50% | +0.50 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.8 | 62.7 | +15.07 | CROX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.87 | +0.17 | CROX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 21.7x | +10.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.20B | $372.21B | -$365.01B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CROX REV | PG REV | CROX GROSS % | PG GROSS % | CROX FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.04B | $84.28B | 58.3% | 51.2% | $659.2M | $14.04B |
| FY 2024 | $4.10B | $84.04B | 58.8% | 51.4% | $923.1M | $16.52B |
| FY 2023 | $3.96B | $82.01B | 44.0% | 44.0% | $752.1M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CROX // BETA 1.04
PG // BETA 0.87